These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30453269)

  • 41. A comprehensive analysis of Candida albicans phosphoproteome reveals dynamic changes in phosphoprotein abundance during hyphal morphogenesis.
    Ghorai P; Irfan M; Narula A; Datta A
    Appl Microbiol Biotechnol; 2018 Nov; 102(22):9731-9743. PubMed ID: 30121747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deguelin induced differentiation of mutated NPM1 acute myeloid leukemia in vivo and in vitro.
    Zhang X; Zhao Z; Yi S; Wen L; He J; Hu J; Ruan J; Fang J; Chen Y
    Anticancer Drugs; 2017 Aug; 28(7):723-738. PubMed ID: 28471807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage.
    Bensimon A; Schmidt A; Ziv Y; Elkon R; Wang SY; Chen DJ; Aebersold R; Shiloh Y
    Sci Signal; 2010 Dec; 3(151):rs3. PubMed ID: 21139141
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid dephosphorylation of p107 following UV irradiation.
    Voorhoeve PM; Watson RJ; Farlie PG; Bernards R; Lam EW
    Oncogene; 1999 Jan; 18(3):679-88. PubMed ID: 9989818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogene c-fos and mutant R175H p53 regulate expression of Nucleophosmin implicating cancer manifestation.
    Senapati P; Dey S; Sudarshan D; Das S; Kumar M; Kaypee S; Mohiyuddin A; Kodaganur GS; Kundu TK
    FEBS J; 2018 Sep; 285(18):3503-3524. PubMed ID: 30085406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nucleophosmin (NPM1)/B23 in the Proteome of Human Astrocytic Cells Restricts Chikungunya Virus Replication.
    Abraham R; Singh S; Nair SR; Hulyalkar NV; Surendran A; Jaleel A; Sreekumar E
    J Proteome Res; 2017 Nov; 16(11):4144-4155. PubMed ID: 28959884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.
    Chang TP; Yu SL; Lin SY; Hsiao YJ; Chang GC; Yang PC; Chen JJ
    Cancer Res; 2010 Feb; 70(4):1656-67. PubMed ID: 20145123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implication of B23/NPM1 in Viral Infections, Potential Uses of B23/NPM1 Inhibitors as Antiviral Therapy.
    Lobaina Y; Perera Y
    Infect Disord Drug Targets; 2019; 19(1):2-16. PubMed ID: 29589547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sodium taurocholate cotransporting polypeptide is a serine, threonine phosphoprotein and is dephosphorylated by cyclic adenosine monophosphate.
    Mukhopadhyay S; Ananthanarayanan M; Stieger B; Meier PJ; Suchy FJ; Anwer MS
    Hepatology; 1998 Dec; 28(6):1629-36. PubMed ID: 9828228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a novel nucleophosmin-interaction motif in the tumor suppressor p14arf.
    Luchinat E; Chiarella S; Franceschini M; Di Matteo A; Brunori M; Banci L; Federici L
    FEBS J; 2018 Mar; 285(5):832-847. PubMed ID: 29283500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two novel NPM1 mutations in a therapy-responder AML patient.
    Pianta A; Fabbro D; Damiani D; Tiribelli M; Fanin R; Franzoni A; Romanello M; Tell G; Di Loreto C; Damante G
    Hematol Oncol; 2010 Sep; 28(3):151-5. PubMed ID: 19593743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphoproteome analysis reveals differences in phosphosite profiles between tumorigenic and non-tumorigenic epithelial cells.
    Winck FV; Belloni M; Pauletti BA; Zanella Jde L; Domingues RR; Sherman NE; Paes Leme AF
    J Proteomics; 2014 Jan; 96():67-81. PubMed ID: 24211406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.
    Pozzo F; Bittolo T; Vendramini E; Bomben R; Bulian P; Rossi FM; Zucchetto A; Tissino E; Degan M; D'Arena G; Di Raimondo F; Zaja F; Pozzato G; Rossi D; Gaidano G; Del Poeta G; Gattei V; Dal Bo M
    Leukemia; 2017 Nov; 31(11):2407-2415. PubMed ID: 28321119
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical detection of cytoplasmic nucleophosmin in formalin-fixed paraffin-embedded marrow trephine biopsies in acute myeloid leukaemia.
    Lit BM; Kwong YL; Wong KF
    J Clin Pathol; 2016 May; 69(5):409-14. PubMed ID: 26500335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Downregulation of nucleophosmin expression inhibited proliferation and induced apoptosis in salivary gland adenoid cystic carcinoma.
    Li S; Zhang X; Zhou Z; Huang Z; Liu L; Huang Z
    J Oral Pathol Med; 2017 Mar; 46(3):175-181. PubMed ID: 27501253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
    Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
    Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting the NAT10/NPM1 axis abrogates PD-L1 expression and improves the response to immune checkpoint blockade therapy.
    Qin G; Bai F; Hu H; Zhang J; Zhan W; Wu Z; Li J; Fu Y; Deng Y
    Mol Med; 2024 Jan; 30(1):13. PubMed ID: 38243170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic analysis of the impact of phosphorylation and O-GlcNAcylation on protein subcellular localization.
    Xu S; Suttapitugsakul S; Tong M; Wu R
    Cell Rep; 2023 Jul; 42(7):112796. PubMed ID: 37453062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression.
    Na J; Lee CH; Chung JK; Youn H
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The EGFR/ErbB inhibitor neratinib modifies the neutrophil phosphoproteome and promotes apoptosis and clearance by airway macrophages.
    Herman KD; Wright CG; Marriott HM; McCaughran SC; Bowden KA; Collins MO; Renshaw SA; Prince LR
    Front Immunol; 2022; 13():956991. PubMed ID: 35967296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.